Whitney & Co., a US-based private equity and hedge fund firm, launched Asia's first healthcare hedge fund in August 2004. The fund currently has $160 million under management and is targeting a return of 15% to 18% per annum, with 5% volatility. In its first month of trading, the fund was up 2%. Goldman Sachs has been appointed as the fund's prime broker and administrator.